InSilicoTrials Awarded 2023 Innovation Radar Prize Established by European Commission in AI and Smart Devices Category

The Innovation Radar Prize, initiated by the European Commission in 2015, celebrates innovators who have received EU funding and are working to transition their innovations from the laboratory to the market. This year's Innovation Radar Summit, held in Lisbon in partnership with Eura AG, Dealroom.co, the European Startup Nations Alliance (ESNA), Startup Lisboa, and Microsoft, showcased the most promising innovations that have the potential to transform industries and improve the quality of life for people across Europe.

The Innovation Radar Prize, initiated by the European Commission in 2015, celebrates innovators who have received EU funding and are working to transition their innovations from the laboratory to the market. This year's Innovation Radar Summit, held in Lisbon in partnership with Eura AG, Dealroom.co, the European Startup Nations Alliance (ESNA), Startup Lisboa, and Microsoft, showcased the most promising innovations that have the potential to transform industries and improve the quality of life for people across Europe.

The European Health and Digital Executive Agency (HaDEA) recently spotlighted InSilicoTrials as a finalist in this prestigious competition, detailing in an article how three HaDEA beneficiaries, including IST, were among the 12 finalists. IST is actively involved in four projects funded under Horizon 2020 or Horizon Europe, further solidifying our commitment to advancing healthcare and pharmaceutical research:

Luca Emili, CEO of InSilicoTrials, expressed his appreciation for IST participation in these projects, saying, "Our involvement in the SimCardioTest, BRAINTEASER, In Silico World, and METASTRA projects, supported by EU funding, enables us to contribute to the democratization of in-silico methods in the development of new drugs and medical devices. The EU's support is vital, providing resources and a collaborative network essential for enhancing predictive tools and data-driven healthcare solutions, ultimately transforming the landscape of medical research and patient care."

InSilicoTrials is honored to accept the 2023 Innovation Radar Prize in the AI and Smart Devices category and extends our gratitude to the European Commission, HaDEA, and our partners for acknowledging the significance of our work in reshaping the landscape of medical research and patient care.

Photo: https://mma.prnewswire.com/media/2278108/Innovation_Radar_Prize.jpg

View original content:https://www.prnewswire.co.uk/news-releases/insilicotrials-awarded-2023-innovation-radar-prize-established-by-european-commission-in-ai-and-smart-devices-category-301989581.html